Antiretrovirals in Development

See also: Interleukin | FDA Review and Approval of New Drugs | HIV Drugs No Longer in Development

Show Archived (Historical) Articles

Overview

The Once and Future King: What Will Replace Atripla Atop the First-Line HIV Treatment Realm? (Feb. 19, 2010; 3:39 p.m. Pacific Time)
A blog entry from CROI 2010 by Gerald Pierone Jr., M.D.
In The 17th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
ViiV Vows Joint Venture Will Help Fight HIV (November 10, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
GlaxoSmithKline, Pfizer Formally Launch Company to Develop New HIV Treatments (November 3, 2009)
Two of the major pharmaceutical companies producing antiretrovirals have launched a new joint company focused solely on HIV: ViiV Healthcare.
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Drug Watch: Two New Pharmacoenhancers Give HAART a Boost (Summer/Fall 2009)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
HIV Antiretrovirals in Development: An Update From ICAAC 2009 (October 22, 2009)
In The 49th Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
Immune Therapies in Development (September 24, 2009)
To read PDF, click here.
From AIDS InfoNet
Small Clinical Trial Examines Drug's Ability to Reduce HIV in Body (July 22, 2009)
In Kaiser Daily U.S. HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Antiretroviral Drug Development in 2009 (July 2009)
To read PDF, click here.
In TAG 2009 Pipeline Report, from Treatment Action Group
Gilead Initiates Phase II Clinical Trial of Integrase-Based, Single-Tablet, Once-Daily Regimen for the Treatment of HIV (April 17, 2009)
Study will assess safety and efficacy of single-tablet regimen containing elvitegravir boosted by GS 9350 and Truvada compared to Atripla.
From Gilead Sciences, Inc.
HIV Drugs in the Pipeline (March/April 2009)
A concise summary of drugs further along in development.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
Combining New Drugs (Winter/Spring 2009)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
New Pharmaco-Enhancers (Winter/Spring 2009)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
The Coming Crisis (October 2008)
To read PDF, click here.
In GMHC Treatment Issues, from Gay Men's Health Crisis
The Coming Crisis in HIV Drug Development (June 16, 2008)
From Project Inform
Novel HIV Therapy Suffers Stunning Setback (June 12, 2008)
From Project Inform
Compound Has Potential for New Class of AIDS Drugs (May 14, 2008)
From University of Michigan
Update From CROI 2008 on Experimental Drugs (April 2008)
To read PDF, click here.
In Project Inform Perspective, from Project Inform
Update on New Antiretroviral Drugs (November/December 2007)
An interview with Harold Kessler, M.D.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
2007 Antiretrovirals in Development Pipeline (March 23, 2007)
From Treatment Action Group
HIV Antiretroviral Agents in Development (March 30, 2006)
An overview from Edwin DeJesus, M.D.
From The Body PRO
Oral Abstracts and Research Overview: Antiretroviral Therapy I: New Agents and New Insights (MP3) (February 6, 2006)
Podcast of presentations from CROI 2006; also available as an audio Webcast and a video Webcast.
From 13th Conference on Retroviruses and Opportunistic Infections
The Future of HIV Treatment: I Left My HAART in the 20th Century (July 2001)
Charles Flexner, M.D., ruminates on the future of HIV treatment.
In Hopkins HIV Report